Chronic Myeloproliferative Disorders
Edited By Tariq Mughal, John M. Goldman Copyright 2013
by CRC Press
by CRC Press
Also available as eBook on:
With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.
Part I - Bcr/Abl positive Chronic Myeloproliferative Disorders 1. History 2. Cytogenetics & Molecular Biology 3. Risk Stratification Models 4. Clinical Aspects 5. Current Treatment Options 6. Emerging treatment Options 7. Transplant Options 8. Monitoring response to therapy 9. Immunotherapy 10. Furture Directions Part II - Bcr/Abl negative Chronic Myeloproliferative Disorders 1. History 2. Ph-negative Chronic Myelproliferative Leukemias 3. Systemic mastocytosis 4. Polycythemia vera 5. Idiopathic myelofibrosis 6. Essential thrombocythemia 7. Transplant Options 8. Therapeutic strategies